These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 20864079)

  • 1. Is prior cholecystectomy associated with decreased survival in patients with resectable pancreatic adenocarcinoma following pancreaticoduodenectomy?
    Schiffman SC; Chu CK; Park J; Russell M; Keilin S; Kooby DA; Scoggins CR; McMasters KM; Martin RC
    Am J Surg; 2011 Apr; 201(4):519-24. PubMed ID: 20864079
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Improved survival following pancreaticoduodenectomy to treat adenocarcinoma of the pancreas: the influence of operative blood loss.
    Kazanjian KK; Hines OJ; Duffy JP; Yoon DY; Cortina G; Reber HA
    Arch Surg; 2008 Dec; 143(12):1166-71. PubMed ID: 19075167
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chemoradiation followed by chemotherapy before resection for borderline pancreatic adenocarcinoma.
    Brown KM; Siripurapu V; Davidson M; Cohen SJ; Konski A; Watson JC; Li T; Ciocca V; Cooper H; Hoffman JP
    Am J Surg; 2008 Mar; 195(3):318-21. PubMed ID: 18308038
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Total pancreatectomy for pancreatic adenocarcinoma: evaluation of morbidity and long-term survival.
    Reddy S; Wolfgang CL; Cameron JL; Eckhauser F; Choti MA; Schulick RD; Edil BH; Pawlik TM
    Ann Surg; 2009 Aug; 250(2):282-7. PubMed ID: 19638918
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Does intraoperative radiation therapy improve local tumor control in patients undergoing pancreaticoduodenectomy for pancreatic adenocarcinoma? A propensity score analysis.
    Showalter TN; Rao AS; Rani Anne P; Rosato FE; Rosato EL; Andrel J; Hyslop T; Xu X; Berger AC
    Ann Surg Oncol; 2009 Aug; 16(8):2116-22. PubMed ID: 19437078
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Outcome of pancreaticoduodenectomy with extended retroperitoneal lymphadenectomy for adenocarcinoma of the head of the pancreas.
    Yang YM; Wan YL; Tian XD; Zhuang Y; Huang YT
    Chin Med J (Engl); 2005 Nov; 118(22):1863-9. PubMed ID: 16313840
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic relevance of lymph node ratio following pancreaticoduodenectomy for pancreatic cancer.
    Pawlik TM; Gleisner AL; Cameron JL; Winter JM; Assumpcao L; Lillemoe KD; Wolfgang C; Hruban RH; Schulick RD; Yeo CJ; Choti MA
    Surgery; 2007 May; 141(5):610-8. PubMed ID: 17462460
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term survival after pancreatoduodenectomy for pancreatic adenocarcinoma: is cure possible?
    Schnelldorfer T; Ware AL; Sarr MG; Smyrk TC; Zhang L; Qin R; Gullerud RE; Donohue JH; Nagorney DM; Farnell MB
    Ann Surg; 2008 Mar; 247(3):456-62. PubMed ID: 18376190
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Surgical treatment of cancer of the pancreas].
    Lazorthes F
    Cancer Radiother; 1997; 1(5):537-41. PubMed ID: 9587386
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pancreatic cancer and pancreaticoduodenectomy in elderly patient: morbidity and mortality are increased. Is it the real life?
    Ouaïssi M; Sielezneff I; Pirrò N; Merad A; Loundou A; Chaix JB; Dahan L; Ries P; Seitz JF; Payan MJ; Consentino B; Sastre B
    Hepatogastroenterology; 2008; 55(88):2242-6. PubMed ID: 19260514
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Accuracy of staging node-negative pancreas cancer: a potential quality measure.
    Tomlinson JS; Jain S; Bentrem DJ; Sekeris EG; Maggard MA; Hines OJ; Reber HA; Ko CY
    Arch Surg; 2007 Aug; 142(8):767-723; discussion 773-4. PubMed ID: 17709731
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neoadjuvant therapy and biliary decompression lower biliary and pancreatic juice vascular endothelial growth factor levels in patients with periampullary adenocarcinoma.
    Berger AC; Watson JC; Ross EA; Zalatoris A; Hoffman JP
    Am Surg; 2004 Feb; 70(2):169-73; discussion 173-4. PubMed ID: 15011922
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic factors associated with resectable adenocarcinoma of the head of the pancreas.
    Millikan KW; Deziel DJ; Silverstein JC; Kanjo TM; Christein JD; Doolas A; Prinz RA
    Am Surg; 1999 Jul; 65(7):618-23; discussion 623-4. PubMed ID: 10399969
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A prospective randomized trial comparing standard pancreatoduodenectomy with pancreatoduodenectomy with extended lymphadenectomy in resectable pancreatic head adenocarcinoma.
    Farnell MB; Pearson RK; Sarr MG; DiMagno EP; Burgart LJ; Dahl TR; Foster N; Sargent DJ;
    Surgery; 2005 Oct; 138(4):618-28; discussion 628-30. PubMed ID: 16269290
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Resected periampullary adenocarcinoma: 5-year survivors and their 6- to 10-year follow-up.
    Riall TS; Cameron JL; Lillemoe KD; Winter JM; Campbell KA; Hruban RH; Chang D; Yeo CJ
    Surgery; 2006 Nov; 140(5):764-72. PubMed ID: 17084719
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Postresection survival outcomes of pancreatic cancer according to demographic factors and socio-economic status.
    Kuhn Y; Koscielny A; Glowka T; Hirner A; Kalff JC; Standop J
    Eur J Surg Oncol; 2010 May; 36(5):496-500. PubMed ID: 19748206
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pylorus-preserving pancreaticoduodenectomy.
    Yeo CJ
    Surg Oncol Clin N Am; 1998 Jan; 7(1):143-56. PubMed ID: 9443992
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pancreaticoduodenectomy for periampullary adenocarcinoma.
    Andersen HB; Baden H; Brahe NE; Burcharth F
    J Am Coll Surg; 1994 Nov; 179(5):545-52. PubMed ID: 7952456
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Peritoneal cytology in patients with potentially resectable adenocarcinoma of the pancreas.
    Meszoely IM; Lee JS; Watson JC; Meyers M; Wang H; Hoffman JP
    Am Surg; 2004 Mar; 70(3):208-13; discussion 213-4. PubMed ID: 15055843
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use of expandable metallic biliary stents in resectable pancreatic cancer.
    Wasan SM; Ross WA; Staerkel GA; Lee JH
    Am J Gastroenterol; 2005 Sep; 100(9):2056-61. PubMed ID: 16128952
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.